Forced sterilization, Dobbs and a long history of regulating people’s bodies
By Zari Taylor,
The Daily Tar Heel
| 10. 11. 2022
It’s been nearly four months since the United States Supreme Court overturned the constitutional right to abortion, triggering restrictions in numerous states and a national debate on reproductive rights. The regulation of women’s bodies has a long history in the U.S., not only regarding abortion, wherein women exercise the autonomy to make decisions, but also the forced sterilization of women — in which the state made decisions on their behalf.
More than 60,000 people were sterilized in the U.S. in the 20th century on the basis of eugenics — the majority of them women. Eugenics is a belief that future generations of humans could be improved through the careful selection of who reproduces. It was greatly influenced by Charles Darwin’s theory of natural selection and used scientific language to justify discrimination against those deemed “unfit” to have children.
The U.S. was a leader in eugenics, with Indiana passing the world’s first sterilization law in 1907. Over 30 states followed suit, with sterilizations peaking in the 1930s and 1940s. While sterilization began by targeting “mentally defective,” “feeble-minded” or disabled individuals, it...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...